Modeling Pathogenesis of Huntington’s Disease with Inducible Neuroprogenitor Cells

被引:0
|
作者
G. Dong
J. M. Ferguson
A. J. Duling
R. G. Nicholas
D. Zhang
K. Rezvani
S. Fang
M. J. Monteiro
S. Li
X-J. Li
H. Wang
机构
[1] University of South Dakota,Division of Basic Biomedical Sciences, Sanford School of Medicine
[2] University of South Dakota,Department of Biology
[3] University of Maryland,Center for Biomedical Engineering and Technology
[4] Emory University School of Medicine,Department of Human Genetics
来源
Cellular and Molecular Neurobiology | 2011年 / 31卷
关键词
Huntington’s disease; Pathogenesis; Huntingtin; Polyglutamine; Neuron; Neuroprogenitor;
D O I
暂无
中图分类号
学科分类号
摘要
Huntington’s disease (HD) is caused by an abnormal expansion of CAG trinucleotide repeats encoding polyglutamine (polyQ) in the first exon of the huntingtin (htt) gene. Despite considerable efforts, the pathogenesis of HD remains largely unclear due to a paucity of models that can reliably reproduce the pathological characteristics of HD. Here, we report a neuronal cell model of HD using the previously established tetracycline regulated rat neuroprogenitor cell line, HC2S2. Stable expression of enhanced green fluorescence protein tagged htt exon 1 (referred to as 28Q and 74Q, respectively) in the HC2S2 cells did not affect rapid neuronal differentiation. However, compared to the cells expressing wild type htt, the cell line expressing mutant htt showed an increase in time-dependent cell death and neuritic degeneration, and displayed increased vulnerability to oxidative stress. Increased protein aggregation during the process of neuronal aging or when the cells were exposed to oxidative stress reagents was detected in the cell line expressing 74Q but not in its counterpart. These results suggest that the neuroprogenitor cell lines mimic the major neuropathological characteristics of HD and may provide a useful tool for studying the neuropathogenesis of HD and for high throughput screening of therapeutic compounds.
引用
收藏
页码:737 / 747
页数:10
相关论文
共 50 条
  • [21] Huntingtin and the molecular pathogenesis of Huntington's disease - Fourth in molecular medicine review series
    Landles, C
    Bates, GP
    EMBO REPORTS, 2004, 5 (10) : 958 - 963
  • [22] Genetic criteria for Huntington's disease pathogenesis
    Gusella, James F.
    MacDonald, Marcy
    BRAIN RESEARCH BULLETIN, 2007, 72 (2-3) : 78 - 82
  • [23] Huntington's disease: pathogenesis to animal models
    Kumar, Puneet
    Kalonia, Harikesh
    Kumar, Anil
    PHARMACOLOGICAL REPORTS, 2010, 62 (01) : 1 - 14
  • [24] Huntington's disease: Pathogenesis to animal models
    Kumar P.
    Kalonia H.
    Kumar A.
    Pharmacological Reports, 2010, 62 (1) : 1 - 14
  • [25] The early cellular pathology of Huntington's disease
    Li, XJ
    MOLECULAR NEUROBIOLOGY, 1999, 20 (2-3) : 111 - 124
  • [26] The early cellular pathology of Huntington’s disease
    Xiao-Jiang Li
    Molecular Neurobiology, 1999, 20 : 111 - 124
  • [27] Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy
    Chang, Renbao
    Liu, Xudong
    Li, Shihua
    Li, Xiao-Jiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2179 - 2188
  • [28] Shaping the role of mitochondria in the pathogenesis of Huntington's disease
    Costa, Veronica
    Scorrano, Luca
    EMBO JOURNAL, 2012, 31 (08) : 1853 - 1864
  • [29] Excitotoxic neuronal death and the pathogenesis of Huntington's disease
    Sanchez, Ana Maria Estrada
    Mejia-Toiber, Jana
    Massieu, Lourdes
    ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (03) : 265 - 276
  • [30] Gut Microbiota as a Modifier of Huntington's Disease Pathogenesis
    Khoshnan, Ali
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (02) : 133 - 147